Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
ASNDAscendis Pharma A/S | $8.43bn | n/a | n/a |
CERECerevel Therapeutics Holdings | $7.60bn | n/a | n/a |
VKTXViking Therapeutics | $7.56bn | n/a | n/a |
CYTKCytokinetics | $7.48bn | n/a | n/a |
EXELExelixis | $6.92bn | 35.29 | n/a |
PCVXVaxcyte | $6.71bn | n/a | n/a |
RETAReata Pharmaceuticals | $6.52bn | n/a | n/a |
IONSIonis Pharmaceuticals | $6.08bn | n/a | n/a |
RVMDRevolution Medicines | $5.94bn | n/a | n/a |
ISEEIVERIC bio | $5.51bn | n/a | n/a |
BPMCBlueprint Medicines | $5.34bn | n/a | n/a |
CRSPCrispr Therapeutics AG | $5.15bn | n/a | n/a |
MDGLMadrigal Pharmaceuticals | $4.96bn | n/a | n/a |
KRYSKrystal Biotech | $4.95bn | n/a | n/a |
HALOHalozyme Therapeutics | $4.91bn | 18.27 | n/a |
SYNHSyneos Health | $4.46bn | 28.55 | n/a |
BHVNBiohaven | $4.33bn | n/a | n/a |
IMVTImmunovant | $4.26bn | n/a | n/a |
ALPNAlpine Immune Sciences | $4.22bn | n/a | n/a |
NUVLNuvalent | $4.20bn | n/a | n/a |